Paper533258
Bronchial secretion levels of amikacin.
Dull WL and 2 others. Antimicrob Agents Chemother, 1979. Cited by 39 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Bronchial secretion levels of amikacin. Papers, record 533258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/533258
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amikacin | Major topic |
| Bronchi | Major topic |
| Kanamycin | Major topic |
| Aged | |
| Half-Life | |
| Humans | |
| Male | |
| Middle Aged | |
| Time Factors |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,157,342 | Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4157342 | PubMed |
| 2 | 374,019 | The concentration of tobramycin in bronchial secretions. | Chest | 1979 | https://conductscience.org/library/papers/374019 | PubMed |
| 3 | 374,017 | Endotracheally administered antibiotics for gram-negative bronchopneumonia. | Chest | 1979 | https://conductscience.org/library/papers/374017 | PubMed |
| 4 | 319,355 | Controlled comparison of amikacin and gentamicin. | N Engl J Med | 1977 | https://conductscience.org/library/papers/319355 | PubMed |
| 5 | 279,981 | Pharmacokinetic study of beta-lactam antibiotics in bronchial secretions. | Scand J Infect Dis Suppl | 1978 | https://conductscience.org/library/papers/279981 | PubMed |
| 6 | 730,392 | [Tobramycin Concentration in Human Lung Tissue (author's transl)]. | Infection | 1978 | https://conductscience.org/library/papers/730392 | PubMed |
| 7 | 868,912 | Amikacin in the treatment of gram-negative pneumonia. | Am J Med | 1977 | https://conductscience.org/library/papers/868912 | PubMed |
| 8 | 868,911 | Amikacin treatment of pulmonary infections involving gentamicin-resistant gram-negative bacilli. | Am J Med | 1977 | https://conductscience.org/library/papers/868911 | PubMed |
| 9 | 864,291 | Penetration of tobramycin into infected extravascular fluids and its therapeutic effectiveness. | J Infect Dis | 1977 | https://conductscience.org/library/papers/864291 | PubMed |
| 10 | 825,588 | Susceptibility of recently isolated bacteria to amikacin in vitro: comparisons with four other aminoglycoside antibiotics. | J Infect Dis | 1976 | https://conductscience.org/library/papers/825588 | PubMed |
| 11 | 977,997 | Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum. | J Infect Dis | 1976 | https://conductscience.org/library/papers/977997 | PubMed |
| 12 | 4,146,250 | Concentrations of gentamicin and carbenicillin in bronchial secretions. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4146250 | PubMed |
| 13 | 168,036 | Diagnostic fiberoptic bronchoscopy: Techniques and results of biopsy in 600 patients. | Chest | 1975 | https://conductscience.org/library/papers/168036 | PubMed |
| 14 | 4,318,047 | Ampicillin levels in sputum, serum, and saliva. | Thorax | 1970 | https://conductscience.org/library/papers/4318047 | PubMed |
| 15 | 4,210,297 | Comparative pharmacokinetics of amikacin and kanamycin. | Clin Pharmacol Ther | 1974 | https://conductscience.org/library/papers/4210297 | PubMed |
| 16 | 4,790,621 | Cephalexin concentrations in sputum during acute respiratory infections. | Antimicrob Agents Chemother | 1973 | https://conductscience.org/library/papers/4790621 | PubMed |
| 17 | 5,000,612 | Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. | J Pediatr | 1971 | https://conductscience.org/library/papers/5000612 | PubMed |
| 18 | 807,603 | Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration. | J Clin Pharmacol | 1975 | https://conductscience.org/library/papers/807603 | PubMed |
| 19 | 1,200,524 | Amikacin therapy for serious gram-negative bacillary infections. | Ann Intern Med | 1975 | https://conductscience.org/library/papers/1200524 | PubMed |
| 20 | 1,155,479 | Penetration of antimicrobial agents into bronchial secretions. | Am J Med | 1975 | https://conductscience.org/library/papers/1155479 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27,458,224 | Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27458224 | PubMed |
| 27,458,221 | Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27458221 | PubMed |
| 27,458,215 | Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of Tuberculosis. | Antimicrob Agents Chemother | 2016 | https://conductscience.org/library/papers/27458215 | PubMed |
| 26,643,339 | Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model. | Antimicrob Agents Chemother | 2015 | https://conductscience.org/library/papers/26643339 | PubMed |
| 21,709,076 | Quantification of amikacin in bronchial epithelial lining fluid in neonates. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21709076 | PubMed |
| 15,536,528 | Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness. | Intensive Care Med | 2004 | https://conductscience.org/library/papers/15536528 | PubMed |
| 8,882,302 | Drug monitoring in nonconventional biological fluids and matrices. | Clin Pharmacokinet | 1996 | https://conductscience.org/library/papers/8882302 | PubMed |
| 7,695,320 | Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily. | Antimicrob Agents Chemother | 1995 | https://conductscience.org/library/papers/7695320 | PubMed |
| 6,810,757 | Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6810757 | PubMed |
| 3,606,080 | Penetration of cefotaxime into respiratory secretions. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3606080 | PubMed |
| 2,692,939 | Clinical pharmacokinetics in infants and children. A reappraisal. | Clin Pharmacokinet | 1989 | https://conductscience.org/library/papers/2692939 | PubMed |
| 1,724,642 | Drug treatment of pneumonia in the hospital. What are the choices? | Drugs | 1991 | https://conductscience.org/library/papers/1724642 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/533258
GET https://conductscience.org/api/papers/v1/533258/references?page=2